BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 6924609)

  • 1. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
    Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
    Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes in hypertrophic cardiomyopathy and ischemic heart disease].
    Kardaszewicz B; Rogala E; Tendera M; Kardaszewicz P; Jarzab J
    Kardiol Pol; 1991; 34(1):21-4. PubMed ID: 1828843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles infection. Involvement of the complement system.
    Charlesworth JA; Pussell BA; Roy LP; Robertson MR; Beveridge J
    Clin Exp Immunol; 1976 Jun; 24(3):401-6. PubMed ID: 939047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
    Brandeis WE; Tan C; Wang Y; Good RA; Day NK
    Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
    Teshima H; Wanebo H; Pinsky C; Day NK
    J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement abnormalities during an epidemic of group B meningococcal infection in children.
    Beatty DW; Ryder CR; Heese HD
    Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis: significance of changes in complement components.
    Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
    Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
    Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of circulating and tissue-fixed immune complexes in cutaneous necrotizing vasculitis.
    Imamura S; Yanase K
    Acta Derm Venereol; 1980; 60(5):389-92. PubMed ID: 6162308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes and complement activation in primary biliary cirrhosis.
    Wands JR; Dienstag JL; Bhan AK; Feller ER; Isselbacher KJ
    N Engl J Med; 1978 Feb; 298(5):233-7. PubMed ID: 619265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
    Yanase K; Imamura S
    Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.